transferrin has been researched along with Neuroendocrine Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grieser, C; Jann, H; Knappe-Drzikova, B; Maasberg, S; Pape, UF; Pascher, A; Pavel, M; Schefold, JC; Sturm, A; Vonderbeck, D; Weylandt, KH; Wiedenmann, B | 1 |
| Büchler, MW; Hartel, M; Huszty, G; Knaebel, HP; Ryschich, E; Schmidt, J | 1 |
2 other study(ies) available for transferrin and Neuroendocrine Tumors
| Article | Year |
|---|---|
Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthropometry; Body Composition; Child; Cross-Sectional Studies; Electric Impedance; Female; Humans; Male; Malnutrition; Neuroendocrine Tumors; Predictive Value of Tests; Retrospective Studies; Serum Albumin; Statistics, Nonparametric; Survival Analysis; Transferrin; Young Adult | 2017 |
Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Topics: Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Flow Cytometry; Humans; Immunohistochemistry; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Receptors, Transferrin; Transferrin | 2004 |